M&A advisory for a healthcare company expanding into European markets

Summary 

We advised a US-based healthcare technology company on its strategic acquisition of a European digital health platform to accelerate market entry and scale operations. The mandate included target screening, valuation, regulatory diligence, and deal structuring. By aligning cross-border M&A strategy with EU healthcare regulations and reimbursement frameworks, we enabled a seamless transaction, optimized valuation, and accelerated the client’s expansion into high-growth European healthcare technology markets.

Identifying Challenges

• Complex EU regulatory landscape, including MDR compliance and country-specific reimbursement pathways, created uncertainty in revenue scalability and post-acquisition integration timelines.
• Fragmented European healthcare systems limited visibility into payer dynamics, pricing structures, and adoption rates across Germany, France, and Nordic markets.
• Valuation discrepancies between US and European HealthTech multiples complicated deal negotiations, particularly around growth-adjusted EBITDA and ARR-based benchmarks.
• Integration risks across data privacy frameworks, including GDPR compliance and cross-border health data interoperability, posed operational and legal challenges post-acquisition.

Our Solution

• Conducted comprehensive target screening across European digital health markets, prioritizing assets with strong regulatory positioning, including DiGA eligibility, established reimbursement pathways, and scalable SaaS-based revenue models aligned with HealthTech investment theses.
• Built a cross-border valuation framework incorporating US and European comparables, normalizing ARR multiples, EBITDA adjustments, and growth premiums to bridge valuation gaps and support negotiation strategy.
• Led regulatory and commercial due diligence, assessing MDR compliance, GDPR exposure, and payer reimbursement structures, ensuring alignment between clinical adoption potential and revenue scalability across key European markets.
• Structured the transaction with earn-out mechanisms linked to regulatory milestones and revenue growth, mitigating valuation risk while aligning incentives between buyer and seller in a dynamic healthcare environment.
• Developed integration strategy covering technology stack alignment, data interoperability, and go-to-market expansion, ensuring seamless onboarding of European operations into the client’s existing HealthTech platform.
• Delivered synergy modeling and post-merger value creation roadmap, quantifying cost efficiencies, cross-selling opportunities, and ARR expansion potential to support internal investment committee approval and investor communication.

Highlights

• Cross-border HealthTech M&A execution expertise demonstrated
• EU regulatory strategy integrated into valuation frameworks
• Advanced ARR-based valuation bridging US-Europe multiples
• GDPR and MDR compliance diligence precision delivered
• Synergy-driven deal structuring with earnout mechanisms
• Scalable European expansion strategy for HealthTech platforms

Highlights Overview:

This engagement highlights our deep expertise in healthcare technology M&A, combining regulatory intelligence with financial rigor. By integrating EU compliance frameworks with valuation and deal structuring, we enabled a high-confidence cross-border transaction, unlocking scalable growth opportunities and ensuring seamless entry into complex European healthcare markets.

Marking the Transition 

From navigating fragmented regulatory and market complexities to executing a structured, value-accretive cross-border acquisition, enabling the client to establish a scalable and compliant European healthcare technology platform.

• Regulatory complexity to strategic clarity
• Fragmentation to unified market entry
• Valuation gaps to alignment achieved
• Risk exposure to controlled execution

Client Testimonial

Their ability to integrate regulatory insight with M&A execution was critical in navigating Europe’s complex healthcare landscape. The transaction was executed with precision and strategic clarity.

CFO, Digital Health Division

Business Impact 

Our healthcare M&A advisory enables HealthTech companies to execute cross-border expansions with precision, combining regulatory expertise, valuation discipline, and integration strategy. For firms entering Europe, we provide actionable insights into reimbursement systems, compliance requirements, and market dynamics. This ensures faster deal execution, reduced regulatory risk, and optimized valuation outcomes—ultimately accelerating market entry and unlocking scalable growth across fragmented but high-potential European healthcare ecosystems.